MultiPlan (NYSE:MPLN – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($5.14) EPS for the quarter, beating analysts’ consensus estimates of ($13.50) by $8.36, Zacks reports. MultiPlan had a negative net margin of 163.30% and a negative return on equity of 12.14%. MultiPlan updated its FY 2025 guidance to EPS.
MultiPlan Stock Performance
MPLN opened at $14.15 on Tuesday. The company has a market cap of $228.82 million, a PE ratio of -0.15 and a beta of 0.13. The company’s 50-day moving average is $17.39. MultiPlan has a 52-week low of $4.80 and a 52-week high of $48.80. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 21.73.
Analyst Ratings Changes
Separately, Citigroup increased their price objective on MultiPlan from $10.00 to $12.50 and gave the stock a “neutral” rating in a report on Friday, January 10th.
MultiPlan Company Profile
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Further Reading
- Five stocks we like better than MultiPlan
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- February’s Top 3 Stock Upgrades: What Investors Need to Know
- CD Calculator: Certificate of Deposit Calculator
- 2 Safe-Haven Stocks Shielded From Import Tariffs
- What is the Dow Jones Industrial Average (DJIA)?
- Nebius Group: A Strategic Entry Point for Investors?
Receive News & Ratings for MultiPlan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MultiPlan and related companies with MarketBeat.com's FREE daily email newsletter.